@entity2753 is a common complication of @entity1504 or surgery. An evaluation should be undertaken to determine whether cerebral salt wasting (CSW) or inappropriate secretion of @entity3488 is present as a cause. Since the treatment principles are completely different in the two pathological states, differential diagnosis is very important. CSW is defined as the renal loss of @entity1372 leading to @entity2753 and decreased extracellular fluid volume. In the literature, it has been noted that mineralocorticoid administration can be useful in CSW cases. We herein present an 11-year-old @entity1 who developed hyponatremic seizures after @entity5 resection. He was diagnosed with CSW on the basis of high urinary @entity1372 excretion and increased urine output, together with signs and symptoms of @entity2700 . Despite intensive fluid and salt therapy, we were unable to decrease the urinary output. Therefore, @entity7842 therapy was administered and his urinary output and @entity1372 excretion were decreased and his serum @entity1372 level was normalized. In conclusion, in addition to fluid and salt replacement, mineralocorticoid supplementation also seems to be a safe and effective treatment for CSW.

XXXX treatment in a @entity1 with severe cerebral salt wasting.

@entity1 :: ('9606', 'Species') :: ['boy'] @entity2700 :: ('MESH:D003681', 'Disease') :: ['dehydration'] @entity5 :: ('MESH:D009369', 'Disease') :: ['intracranial tumor'] @entity1372 :: ('MESH:D012964', 'Chemical') :: ['sodium'] @entity1504 :: ('MESH:D002561', 'Disease') :: ['intracranial disease'] @entity7842 :: ('MESH:D005438', 'Chemical') :: ['fludrocortisone'] @entity2753 :: ('MESH:D007010', 'Disease') :: ['hyponatremia', 'Hyponatremia'] @entity3488 :: ('551', 'Gene') :: ['antidiuretic hormone']
@entity7842 :: (MESH:D005438,Chemical) :: ['Fludrocortisone']
